Berkeley SkyDeck

At Kfobix, our mission is to revolutionize the green energy landscape, making it more efficient and sustainable. In a world increasingly impacted by climate change, our mission is critical: to facilitate a seamless transition to renewable energy sources. We specialize in creating cutting-edge superhydrophobic coatings that prevent ice formation on electrical transmission lines and wind turbines. This not only enhances the reliability of green energy infrastructure but also ensures uninterrupted energy production and transmission. Our innovation extends to the solar energy sector, where we are pioneering anti-dirt coatings. These coatings are designed to maintain the cleanliness of solar panels, thereby maximizing their efficiency and output. Our products represent a leap forward in nanotechnology, offering practical solutions to some of the most pressing challenges in the renewable energy sector. At Kfobix, we are driven by the belief that the future of energy can be cleaner, more reliable, and utterly sustainable. Our journey is marked by relentless research and development, pushing the boundaries of what is possible. By joining forces with us, you become part of a movement that is not just preparing for a sustainable future but actively building it, today. Let’s empower the world together with cleaner, more efficient energy solutions.

Gisens Biotech is a biotechnology firm specializing in bioelectronics and nanotechnology. The company is recognized for its innovative approach to problem-solving and employs advanced technology to enhance its offerings. One of its flagship products is the Nano-Lab, a portable diagnostic device designed to measure and control various biomarkers. This device can accurately analyze concentrations of renal biomarkers such as urea, creatinine, and potassium from a single drop of blood, urine, or saliva. By providing real-time measurements through a user-friendly application, the Nano-Lab enables efficient health monitoring, potentially transforming the way biomarker assessments are conducted and interpreted.

Coreshell Technologies, Inc. is a company focused on developing advanced lithium-ion batteries, primarily targeting the electric vehicle and grid storage markets. Founded in 2017 and based in Berkeley, California, Coreshell has pioneered a nanolayer thin-film coating technology that addresses the degradation issues commonly faced by rechargeable batteries. This innovative coating protects battery electrodes from chemical reactions that can diminish capacity and safety, thereby enhancing the overall performance and durability of the batteries. By seamlessly integrating into existing manufacturing processes, Coreshell's technology aims to significantly improve battery capacity, safety, and cost-effectiveness, facilitating a smoother transition to electric transportation and renewable energy solutions.

Coreshell Technologies, Inc. is a company focused on developing advanced lithium-ion batteries, primarily targeting the electric vehicle and grid storage markets. Founded in 2017 and based in Berkeley, California, Coreshell has pioneered a nanolayer thin-film coating technology that addresses the degradation issues commonly faced by rechargeable batteries. This innovative coating protects battery electrodes from chemical reactions that can diminish capacity and safety, thereby enhancing the overall performance and durability of the batteries. By seamlessly integrating into existing manufacturing processes, Coreshell's technology aims to significantly improve battery capacity, safety, and cost-effectiveness, facilitating a smoother transition to electric transportation and renewable energy solutions.

Serinus Labs, Inc. is a manufacturer of nano-scale silicon gas sensors, established in 2017 and located in Berkeley, California. The company specializes in developing integrated chip-scale gas sensors tailored for various industries, including health and safety, automotive, consumer electronics, and healthcare. Serinus Labs offers custom solutions for both established and emerging gas sensor markets, focusing on applications such as Li-ion battery state-of-health monitoring. Their ultra-low-power trace gas sensors contribute to enhancing battery intelligence, particularly in electric vehicles, addressing critical needs in strategic markets.

Empire Biotechnologies is a therapeutics company focused on developing innovative treatments for diseases of malabsorption. The company is working on an orally delivered protein therapeutic known as Mfge8, which targets integrin biology to enhance nutrient absorption in the digestive system. Founded in 2013, Empire Biotechnologies aims to commercialize advanced platform technologies developed in collaboration with research institutions, including the SUNY College of Nanoscale Science and Engineering and the University of California San Francisco. By addressing significant unmet medical needs, the company strives to provide solutions for various gastrointestinal diseases.

Pinpoint Science, Inc. is engaged in the manufacture of bio-electronic diagnostics aimed at the detection, diagnosis, and surveillance of infectious diseases globally. Founded in 2015 and headquartered in San Francisco, California, the company specializes in a diagnostic device that leverages advanced biosensor technology. This device utilizes swappable cartridges to identify specific pathogens, including viruses, bacteria, and fungi, in various biofluids such as blood and saliva. By employing a unique approach based on functionalized nanopipettes, Pinpoint Science enables label-free electrical detection of biomolecules, offering improved accuracy and cost-effectiveness for the healthcare sector.

Empire Biotechnologies is a therapeutics company focused on developing innovative treatments for diseases of malabsorption. The company is working on an orally delivered protein therapeutic known as Mfge8, which targets integrin biology to enhance nutrient absorption in the digestive system. Founded in 2013, Empire Biotechnologies aims to commercialize advanced platform technologies developed in collaboration with research institutions, including the SUNY College of Nanoscale Science and Engineering and the University of California San Francisco. By addressing significant unmet medical needs, the company strives to provide solutions for various gastrointestinal diseases.

Mekonos Inc. specializes in the design, development, and production of gene and cell therapies, focusing on a proprietary cell-engineering platform that utilizes advanced silicon technology. Founded in 2017 and based in San Francisco, the company has created an integrated system-on-a-chip, which incorporates micro-electromechanical systems (MEMS) to enable the precise injection of single cells using nanoneedles in a parallel architecture. This innovative approach aims to industrialize genome editing and enhance drug discovery and development processes. Mekonos' technology allows for scalable and reliable manufacturing of engineered therapies aimed at addressing genetic diseases, including various forms of cancer, and supports healthcare providers in delivering diverse therapeutic molecules across multiple cell types.

Jadoo Technologies specializes in nanotechnology, offering a platform that features a programmable array of nanostructures, which include bundles of carbon nanotubes that can be individually and electrically addressed. This innovative technology is applicable across various fields, including e-beam nano-writing, lithography, imaging applications, solar cells, biosensors, microarrays, and lab-on-chip devices for clinical use. Additionally, the platform supports research and development in supercapacitors. By leveraging its advanced nanotechnology, Jadoo Technologies aims to deliver transformative solutions for a wide range of industries and applications.